Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors
Incyte Corporation
Incyte Corporation
Quadriga Biosciences, Inc.
Augusta University
Shionogi Inc.
Abramson Cancer Center at Penn Medicine
Swiss Cancer Institute
Valerio Therapeutics
Valerio Therapeutics
INSYS Therapeutics Inc
University of Chicago
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)